UPDATE : Thursday, July 18, 2019
상단여백
HIV prevention pill to get insurance benefit in Korea by Kim Yun-mi 2019-05-30 13:25
Daiichi Sankyo to co-promote Daewoong's hypertension treatment by Lee Han-soo 2019-05-29 14:50
‘Enstilum treats all psoriasis from mild to severe ones’ by Kim Yun-mi 2019-05-28 14:44
Indonesia gave nods to Medytox's hyaluronic acid filler by Lee Han-soo 2019-05-28 14:42
Seoul revokes sales license of Invossa-K, prosecutes Kolon Life Science by Lee Han-soo 2019-05-28 11:31
라인
Corestem applies for FDA meet on Lou Gehrig's drug by Lee Han-soo 2019-05-27 17:51
Medytox suspected of GMP violation filed at anti-corruption commission by Jeong Sae-im 2019-05-27 15:52
HanAll's global partner starts P2 trial of Graves' ophthalmopathy treatment by Lee Han-soo 2019-05-24 14:44
OliX confident of its age-related macular degeneration treatment’s efficacy by Lee Han-soo 2019-05-23 13:48
Sillajen, CHA Hospital to co-develop immunotherapy by Lee Han-soo 2019-05-22 18:26
라인
SK Bioscience's shingles vaccine increases market share by Lee Han-soo 2019-05-22 17:04
Handok, Sanofi to promote vaccines jointly by Lee Han-soo 2019-05-22 15:48
‘Dupixent is sole systemic, long-term treatment for atopic dermatitis’ by Lee Han-soo 2019-05-22 14:44
Ministry grants additional indication to MSD’s immunotherapeutic drug by Lee Han-soo 2019-05-21 14:55
Japan issued safety warning on Lilly’s breast cancer drug. Will Korea, too? by Kim Yun-mi 2019-05-21 14:19
라인
Roche’s breast cancer drug gains more insurance benefits by Lee Han-soo 2019-05-21 10:44
Bridge Biotherapeutics releases first-in-human study for idiopathic pulmonary fibrosis treatment by Lee Han-soo 2019-05-20 15:29
Saxenda's sales surge 3,000 times yoy in Q1 by Lee Han-soo 2019-05-17 14:37
Daewoong launches Nabota in US amid controversy by Lee Han-soo 2019-05-16 16:33
Latecomer SGLT2 inhibitor Steglatro unlikely to get free ride by Kim Yun-mi 2019-05-15 15:30
여백
여백
여백
Back to Top